期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

进行性核上性麻痹研究进展 被引量：3

在线阅读 下载PDF
导出
摘要 进行性核上性麻痹（PSP）为进行性tau蛋白异常聚集所导致的神经系统变性疾病，临床特征性表现为姿势不稳、核上性眼球运动障碍、颈部肌张力障碍、构音障碍、假性延髓麻痹及痴呆等。1904年由Posev首先发现并描述其临床表现，1964年，Steele等将此病列为独立的神经系统疾病。
作者 刘艺鸣 李佳珍
机构地区 山东大学齐鲁医院神经内科
出处 《中国现代神经疾病杂志》 CAS 2011年第1期22-26,共5页 Chinese Journal of Contemporary Neurology and Neurosurgery
关键词 核上麻痹 进行性 综述文献
分类号 R741 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献44

  • 1Steele JC,Richardson JC,Olszewski J.Progressive supranuclear palsy:a heterogeneous degeneration involving the brain stem,basal gemglia and cerebellum with vertical gaze and pseudobulbar palsy,nuchal dystonia and dementia.ArchNeurol,1964,10:333-359.
  • 2Litvan I.Progressive supranuclear palsy//Litvan I.Atypical parkinsonian disorders:clinical and research aspects.New Jersey:Humans Press,2005:287-308.
  • 3Scharg A,Ben-Shlomo Y,Quinn NP.Prevalence of progressive supranuclear palsy and multiple system atrophy:a crosssectional study.Lancet,1999,354:1771-1775.
  • 4Flament S,Delacourte A,Verny M.Abnormal Tau proteins in progressive supranuclear palsy:similarities and differences with the neurofibrillary degeneration of the Alzheimer type.Acta Neuropathol,1991,81:591-596.
  • 5Ksiezak-Reding H,Morgan K,Mattiace LA,et al.Vltrastructure and biochemical composition of paried helical filaments in cortixcbasal degeneration.Am J Pathol,1994,145:1496-1508.
  • 6Borroni B,Goldwarm S,Cerini C,et al.Familial aggregation in Progressive Supranuclear Palsy and Corticobasal Syndrome.Eur J Neurol,2010.[Epub ahead of print].
  • 7Vidal JS,Vidailhet M,Derkinderen P,et al.Familial aggregation in atypical Parkinson's disease:a case control study in multiple system atrophy and progressive supranuclear palsy.J Neurol,2010,257:1388-1393.
  • 8Ros R,Gómez Garre P,Hirano M,et al.Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1.Ann Neurol,2005,57:634-641.
  • 9Cruchage C,Vidal-Taboada JM,Ezquerra M,et al.5'-Upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration.Neurohiol Dis,2009,33:164-170.
  • 10Ezquerra M,Pastor P,Gaig C,et al.Different MAPT haplotypes are associated with Parkinson's disease and progressive supranuclear palsy.Neurobiol Aging,2009.[Epub ahead of print].

二级参考文献40

  • 1Ryman D,Lamb BT.Genetic and environmental modifiers of Alzheimer's disease phenotypes in the mouse.Curr Alzheimer Res,2006,3:465-473.
  • 2Mayeux R.Gene-environment interaction in late-onset Alzheimer disease:the role of apolipoprotein-epsilon 4.Alzheimer Dis Assoc Disord,1998,12 Suppl 3:10-15.
  • 3Kamboh MI,Sanghera DK,Aston CE,et al.Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease.Genet Epidemiol,1997,14:169-180.
  • 4Borroni B,Grassi M,Agosti C,et al.Genetic correlates of behavioral endophenotypes in Alzheimer disease:role of COMT,5-HTTLPR and ApoE polymorphisms.Neurobiol Aging,2006,27:1595-1603.
  • 5Steiner H,Haass C.Intramembrane proteolysis by presenilins.Nat Rev Mol Cell Biol,2000,1:217-224.
  • 6Cirrito JR,Kang JE,Lee J,et al.Endocytosis is required for gynaptic activity-dependent release of amyloid-beta in vivo.Neuron,2008,58:42-51.
  • 7Koo EH,Squazzo SL.Evidence that production and release of amyloid beta-protein involves the endocytic pathway.J Biol Chem,1994,269:17386-17389.
  • 8Hardy J,Selkoe DJ.The amyloid hypothesis of Alzheimer's disease:progress and problems on the road to therapeutics.Science,2002,297:353-356.
  • 9Etcheberrigaray R,Tan M,Dewachter I,et al.Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.Proc Natl Acad Sci USA,2004,101:11141-11146.
  • 10Hwang EM,Kim SK,Sohn JH,et al.Furin is an endogenous regulator of alpha-secretase associated APP processing.Biochem Biophys Res Commun,2006,349:654-659.

共引文献7

同被引文献34

  • 1侯静,陈彤,张晓红,吴卫平,王振福,郭瑞表.103例国人进行性核上性麻痹患者的临床特征[J].神经病学与神经康复学杂志,2010,7(3):135-141. 被引量：14
  • 2Litvan I. Progressive supranuclear palsyff Litvan I. Atypical parkinsonian disorders: clinical and research aspects. New Jersey: Humana Press, 2005 : 287-308.
  • 3Burn DJ, Lees AJ. Progressive supranuelear palsy: where are we now. Lancet Neurol,2002,1 : 359-369.
  • 4Litvan I,Bhatia KP, Burn DJ, et al. Movement Disorder Socie- ty Scientific Issues Committee report: SIC Task Force ap- praisal of clinical diagnostic criteria for Parkinsonian disor- ders. Mov Disord, 2003,18 : 467-486.
  • 5Oba H, Yagishita A, Terada H, et al. New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology, 2005,64(12) :2050-2055.
  • 6Righini A, Antonini A, De Notaris R, et al. MR imaging of the superior profile of the midbrain: differential diagnosis be- tween progressive supranuclear palsy and Pakinson disease. Am J Neuroradiol, 2004,25 (6):927-932.
  • 7Santens P, Sieben A, De Letter M. Repetitive transeranial magnetic stimulation in patients with progressive supranucle- ar palsy: a pilot study. Aete Neural Belg, 2009,109:200-204.
  • 8Zampieri C, Di Fabio RP. Improvement of gaze control after balance and eye movement training in patients with progres- sive supranuclear palsy: a quasi-randomized controlled trial. Arch Phys Med Rehabil, 2009,90 : 263-270.
  • 9Liepeh I, Gaenslen A, Godan J, et al. Rivastigmine for the treatment of dementia in patients with progressive supranu- clear palsy: clinical observations as a basis for power calcula- tions and safety analysis. Alzheimers Dement, 2010,6 : 70-74.
  • 10中华医学会老年医学分会老年神经病学组额颞叶变性专家共识撰写组.额颞叶变性专家共识.中华神经科杂志,2014.47:351-356.

引证文献3

二级引证文献8

中国现代神经疾病杂志
2011年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部